We recognize the substantial unmet medical needs in China and the growing potential of local innovation to drive global advancements
In Conversation
Millions of lives have been saved, millions of people are on treatment, and millions of babies have been born HIV-free. We have achieved a lot, but…
We are a global CDMO committed to delivering exceptional value and quality to our clients. Our extensive experience in meeting the stringent quality standards of global…
My goal has been to try to develop strategies and approaches that – when implemented at scale – could really have an impact on HIV incidence
While we have already received approval for three products in China, our revenue aspirations extend beyond domestic markets
I anticipate continued progress and openness in the region, facilitated by ongoing awareness campaigns and initiatives aimed at breaking down taboos surrounding reproductive health
We have set an ambitious internal target where we aim for 50 percent of our value growth to stem from innovation by 2028 or 2030
Maintaining independence is paramount because we must never be beholden, in any way, to either industry interests or governmental influence.
One of the key challenges lies in keeping pace with rapid technological advancements while ensuring regulatory compliance.
By facilitating collaborations and fostering a supportive regulatory environment, Saudi Arabia can position itself as an attractive destination for clinical trials, contributing significantly to its aspirations…
In 2022, French food supplement exports grew by 20 percent to over EUR 2.5 billion
Saudi Arabia holds immense importance for Olympus, especially within the context of Vision 2030's ambitious goals
